» » Polycystic Ovary Syndrome (Current Issues in Endocrinology and Metabolism)
Download Polycystic Ovary Syndrome (Current Issues in Endocrinology and Metabolism) djvu

Download Polycystic Ovary Syndrome (Current Issues in Endocrinology and Metabolism) djvu

by Andrea M.D. Dunaif,James R. Givens,Florence P. Haseltine

Author: Andrea M.D. Dunaif,James R. Givens,Florence P. Haseltine
Subcategory: Medicine
Language: English
Publisher: Blackwell Science Inc; Illustrated edition edition (February 1, 1992)
Pages: 416 pages
Category: Medicine
Rating: 4.6
Other formats: doc azw lrf txt

Polycystic Ovary Syndrome Current Issues in Endocrinology and Metabolism.

Polycystic Ovary Syndrome Current Issues in Endocrinology and Metabolism.

Polycystic Ovary Syndrome. Current Issues in Endocrinology and Metabolism, vol. 4, Blackwell Scientific, Boston, 1992, pp. 377–384. 18. The Rotterdam PCOS Consensus Workshop Group. Dunaif A, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96:801–810. PubMedGoogle Scholar. 36. Nestler JE, Jacubowicz DJ.

polycystic ovary syndrome body weight obesity insulin resistance basal metabolism adrenoreceptor polymorphism .

polycystic ovary syndrome body weight obesity insulin resistance basal metabolism adrenoreceptor polymorphism autonomic nervous system. 1. Dunaif A, Givens JR, Haseltine FP, Merriam GR (1992) Current issues in endocrinology and metabolism: polycystic ovary syndrome. Blackwell, Boston, pp 377–384Google Scholar. Metabolism 37:287–gle Scholar.

Polycystic ovary syndrome: current and future treatment paradigms. Address correspondence to Melissa H. Hunter, . University Family Medicine, 9298 Medicine Plaza D. Charleston, SC 29406. Am J Obstet Gynecol 1998;179:S101–8. Although serum testosterone levels may be mildly to moderately elevated in women with polycystic ovary syndrome, testosterone levels are generally measured to rule out virilizing tumors.

Free delivery worldwide.

The book is written for a broad audience, particularly practitioners in endocrinology and gynecology. It is useful to clinicians who will be evaluating and treating patients with PCOS, particularly endocrinologists. Polycystic ovary syndrome (PCOS) is the single most common endocrinologic abnormality of women, affecting approximately 1 in 10-to 15 women of reproductive age. It is also the most frequent cause of oligo-ovulatory infertility.

There has been much debate about phenotype and, more recently, genotype.

Heterogeneous by nature, PCOS is defined by a combination of signs and symptoms of androgen excess and ovarian dysfunction in the absence of other specific diagnoses.

Polycystic ovary syndrome (PCOS) is a condition with a range of reproductive and metabolic .

Polycystic ovary syndrome (PCOS) is a condition with a range of reproductive and metabolic features that affects 4–18% of reproductive-age women, depending on the diagnostic criteria used (1,2). PCOS typically involves hormonal imbalances, insulin resistance, and metabolic abnormalities, which significantly increase the risk of infertility, type 2 diabetes, and cardiovascular disease (CVD) (3) and affect quality of life (4). Women.

It is over fifty years since the symptoms of hirsuitism, menstrual dysfunction, infertility and obesity were found to be associated with enlarged cystic ovaries but the cause of the polycystic ovary syndrome remains unkown. This monograph brings together current research in this field and explores areas of promise for future investigation. It begins with an overview of important topics related to PCO such as a history of the syndrome, ovarian morphology and function. This is followed by a review of the fields which may help to clarify the cause and development of PCO. Complications and treatment of PCO are described and possible diagnostic criteria are summarized.